Evidence map›Paper›PMID 35418209›Full record

ArticleProstate cancer and prostatic diseases2022

Dietary inflammatory index and prostate cancer risk: MCC-Spain study.

Macarena Lozano-Lorca, Inmaculada Salcedo-Bellido, Rocío Olmedo-Requena, Gemma Castaño-Vinyals, Pilar Amiano, Nitin Shivappa, James R Hébert, Beatriz Pérez-Gómez, Esther Gracia-Lavedan, Inés Gómez-Acebo and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Prostate cancer and prostatic diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Macarena Lozano-LorcaUniversidad de Granada. Departamento de Medicina Preventiva y Salud Pública, Granada, Spain.ORCID 0000-0001-5282-814X
Inmaculada Salcedo-BellidoUniversidad de Granada. Departamento de Medicina Preventiva y Salud Pública, Granada, Spain. isalcedo@ugr.es.ORCID 0000-0003-4601-198X
Rocío Olmedo-RequenaUniversidad de Granada. Departamento de Medicina Preventiva y Salud Pública, Granada, Spain.ORCID 0000-0003-0054-6700
Gemma Castaño-VinyalsConsortium for Biomedical Research in Epidemiology & Public Health, CIBERESP, Madrid, Spain.ORCID 0000-0003-4468-1816
Pilar AmianoConsortium for Biomedical Research in Epidemiology & Public Health, CIBERESP, Madrid, Spain.
Nitin ShivappaCancer Prevention and Control Program, University of South Carolina, Columbia, SC, USA.
James R HébertCancer Prevention and Control Program, University of South Carolina, Columbia, SC, USA.
Beatriz Pérez-GómezConsortium for Biomedical Research in Epidemiology & Public Health, CIBERESP, Madrid, Spain.ORCID 0000-0002-4299-8214
Esther Gracia-LavedanConsortium for Biomedical Research in Epidemiology & Public Health, CIBERESP, Madrid, Spain.
Inés Gómez-AceboConsortium for Biomedical Research in Epidemiology & Public Health, CIBERESP, Madrid, Spain.
Ana Molina-BarcelóCancer and Public Health Area, FISABIO-Public Health, Valencia, Spain.
Rocío Barrios-RodríguezUniversidad de Granada. Departamento de Medicina Preventiva y Salud Pública, Granada, Spain.
Juan AlguacilConsortium for Biomedical Research in Epidemiology & Public Health, CIBERESP, Madrid, Spain.
Guillermo Fernández-TardónHealth Research Institute of the Principality of Asturias (ISPA), Oncology Institute, University of Oviedo, Oviedo, Asturias, Spain.
Nuria AragonésConsortium for Biomedical Research in Epidemiology & Public Health, CIBERESP, Madrid, Spain.ORCID 0000-0003-0983-2156
Trinidad Dierssen-SotosConsortium for Biomedical Research in Epidemiology & Public Health, CIBERESP, Madrid, Spain.
Dora RomagueraInstituto de Salud Global de Barcelona (ISGlobal), Barcelona, Spain.
Marina PollánConsortium for Biomedical Research in Epidemiology & Public Health, CIBERESP, Madrid, Spain.ORCID 0000-0002-4328-1565
Manolis KogevinasConsortium for Biomedical Research in Epidemiology & Public Health, CIBERESP, Madrid, Spain.ORCID 0000-0002-9605-0461
José-Juan Jiménez-MoleónUniversidad de Granada. Departamento de Medicina Preventiva y Salud Pública, Granada, Spain. jjmoleon@ugr.es.ORCID 0000-0001-7917-6145
MCC-Spain collaborate group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe etiology of prostate cancer (PCa) is not well-known, and the role of diet is not well established. We aimed to evaluate the role of the inflammatory power of the diet, measured by the Dietary Inflammatory Index (DII METHODOLOGY: A population-based multicase-control (MCC-Spain) study was conducted. Information was collected on sociodemographic characteristics, personal and family antecedents, and lifestyles, including diet from a Food Frequency Questionnaire. The inflammatory potential of the diet was assessed using the energy-adjusted Dietary Inflammatory Index (E-DII) based on 30 parameters (a higher score indicates a higher inflammatory capacity of the diet). Tertiles of E-DII were created using the cut-off points from the control group. The International Society of Urology Pathology (ISUP) was grouped as ISUP 1, ISUP 2, or ISUP 3-5. Unconditional logistic regression models were used to estimate adjusted odds ratios (aOR) and 95% confidence intervals (CI) for the association between E-DII score and PCa risk.

resultsA total of 928 PCa cases and 1278 population controls were included. Among PCa cases, the mean value of the E-DII score was 0.18 (SD: 1.9) vs. 0.07 (SD: 1.9) in the control group (p = 0.162). Cases with a more pro-inflammatory diet (3rd tertile) had the highest risk of PCa, aOR

conclusionA positive association was observed between consuming a pro-inflammatory diet and PCa in the MCC-Spain population, specifically for an ISUP grade greater or equal than 2.

Indexed as

Prostatic NeoplasmsCase-Control StudiesDietHumansInflammationMaleRisk FactorsSpain

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.